ST. LOUIS, March 12, 2010 /PRNewswire-FirstCall/ -- As part of today's first joint public workshop exploring competition issues in the agriculture industry, Monsanto Company (NYSE: MON) will participate in a panel discussion about the past, present and future of the seed and trait industry.

NATICK, Mass., June 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer (CEO) Jim Tobin will retire from the Company, and that its board of directors has appointed Ray Elliott the new President and CEO, effective July 13. (Photo: http://www.newscom.com/cgi-bin/prnh/20090625/NE38001 ) "Ten years ago this month, I began my tenure as CEO of Boston Scientific, and two months from now, I will turn 65," said Tobin.

NATICK, Mass., June 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wachovia 19th Annual Mid-Year Equity Conference, June 23 - 24. Jim Tobin, President and Chief Executive Officer, will make a 25-minute presentation on Wednesday, June 24th beginning at approximately 9:00 a.m.

NATICK, Mass., March 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming Cowen and Company 29th Annual Health Care Conference. Jim Tobin, Chief Executive Officer, will make a 35-minute presentation on Tuesday, March 17th, beginning at approximately 3:55 p.m.

By MARK JEWELL BOSTON - Boston Scientific Corp. on Wednesday said it swung to a $76 million third-quarter profit from a big loss a year ago, narrowly beating Wall Street estimates after a string of disappointments since the medical device maker's $27 billion acquisition of Guidant Corp.